Bristol-Myers Squibb Up 1% on New Drug Applications April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Jared Haas Recently, Bristol-Myers Squibb (BMY) submitted new drug applications to the U.S. Food and Drug Administration (FDA).
